Compounded Semaglutide vs. Ozempic/Wegovy: What's the Real Difference?
Compounded semaglutide can cost 80% less than brand-name Ozempic. But is it as safe and effective? We break down the facts.
The active pharmaceutical ingredient in Ozempic and Wegovy — semaglutide — can now be obtained through licensed compounding pharmacies at a fraction of the brand-name cost. A monthly supply of Wegovy at retail can exceed $1,000, while compounded semaglutide through telehealth providers typically runs $99–$299/month. The question patients rightly ask is: what's the actual difference?
Chemically, compounded semaglutide contains the same active ingredient (semaglutide) as Ozempic and Wegovy, prepared by licensed 503A compounding pharmacies from pharmaceutical-grade raw materials. The key difference is that compounded medications are not FDA-approved finished products — they are patient-specific preparations made by pharmacies operating under a different regulatory framework than mass-manufactured drugs.
This distinction matters in practice. High-quality compounding pharmacies — PCAB accredited, using USP 797/800 clean rooms, performing in-house quality testing — produce compounded semaglutide that is chemically identical to the brand name product in terms of active ingredient. Lower-quality operations may cut corners on sterility, purity testing, or ingredient sourcing.
The FDA has taken action against pharmacies producing adulterated or mislabeled compounded semaglutide, which underscores the importance of choosing providers who use only accredited pharmacies. On PeptideWinner, all listed providers are verified to use PCAB-accredited or equivalent licensed compounders.
For most patients who cannot afford or access Ozempic/Wegovy, compounded semaglutide from a reputable telehealth provider represents a legitimate and significantly more affordable pathway to the same active treatment. Providers like Heally, Evolve Telemed, and Vitality Clinic Online are among those with strong compounded semaglutide programs.
Peptides mentioned in this article: